Symproic (naldemedine)

Manufacturer:
Collegium
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
  • Manufacturer Website
Enrollment Forms:
Synergen Prescription Form

Approved Indication:

treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation

Conditions:

  • Opioid-Induced Constipation (OIC)

Therapeutic Area:

  • Gastroenterology